Description
What this story covers
Zoetis reported Q2 revenue of $2.46B, up 4% (5% operational), driven by companion animal growth and MFA divestiture benefits. Gross margins rose to 73.6%, net income up 15%. Strong liquidity supports R&D and shareholder returns amid trade risks and tax changes.
Story snapshot
CompanyZoetis Inc.
TickerZTS
VariantStandard detailed
Duration9:53
Filing type10-Q
PeriodQ2 2025
IndustryHealthcare & Pharmaceuticals
Accession0001555280-25-000261
Full Story Script
Content not available for this story.
